INTERNATIONAL PATENT: CANTAI THERAPEUTICS INC. FILES APPLICATION FOR "ENGINEERED TL1A TARGETING REGIONS AND METHODS OF USE"

GENEVA, March 31 -- CANTAI THERAPEUTICS INC. (3675 Market Street, Suite 200Philadelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/047029) for "ENGINEERED TL1A TARGETING REGIONS AND METHODS OF USE" on Sep 18, 2025. With publication no. WO/2026/064545, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VEMURI, Geeta (c/o Cantai Therapeutics Inc.3675 Market Street, Suite 200Philadelphia, Pennsylvania 19104)

Abstract: Provided herein are compositions, and methods of making and use of the compositions, wherein ...